|
|
| Name
: |
James C. Mullen |
| Title
: |
President, Chief Executive Officer, Director |
| Since: |
11/12/2003 |
|
|
|
|
| Name
: |
Paul J. Clancy |
| Title
: |
Executive Vice President and Chief Financial Officer |
| Since: |
08/2007 |
|
|
|
|
| Name
: |
Cecil B. Pickett |
| Title
: |
President of Research and Development; Director |
| Since: |
09/2006 |
|
|
|
|
| Name
: |
Susan H. Alexander |
| Title
: |
Executive Vice President, General Counsel, Corporate Secretary |
| Since: |
01/30/2006 |
|
|
|
|
| Name
: |
Craig E. Schneier |
| Title
: |
Executive Vice President - Human Resources |
| Since: |
11/12/2003 |
|
|
|
|
| Name
: |
Bruce R. Ross |
| Title
: |
Chairman of the Board |
| Since: |
01/2006 |
|
|
|
|
| Name
: |
John M. Dunn |
| Title
: |
Executive Vice President, New Ventures |
| Since: |
01/10/2002 |
|
|
|
|
| Name
: |
Mark C. Wiggins |
| Title
: |
Executive Vice President - Corporate and Business Development |
| Since: |
05/1998 |
|
|
|
|
| Name
: |
Michael F. MacLean |
| Title
: |
Senior Vice President, Chief Accounting Officer, Controller |
| Since: |
10/02/2006 |
|
|
|
|
| Name
: |
Robert A. Hamm |
| Title
: |
Executive Vice President, Pharmaceutical Operations & Technology |
| Since: |
10/2007 |
|
|